This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Point Of Care Testing Market And Forecast To 2016: Global Analysis

Figure 4 17: Global – Pregnancy & Fertility Testing Market (Million US$), 2009 – 2011

Figure 4 18: Global – Forecast for Pregnancy & Fertility Testing Market (Million US$), 2012 – 2016

Figure 4 19: Global – Tumor Marker Testing Market (Million US$), 2009 – 2011

Figure 4 20: Global – Forecast for Tumor Marker Testing Market (Million US$), 2012 – 2016

Figure 6 1: Global (WHO Region) – Total Male Deaths by Broad Cause Group (Million), 2008Figure 6 2: Global (WHO Region) – Total Female Deaths by Broad Cause Group (Million), 2008

List of Tables:

Table 5 1: Global – Merger & Acquisition in Point of Care Testing (Million US$), 2006 – 2012

Table 5 2: Merger & Acquisition in Major Hospital & Clinics (Million US$), 2011 – 2012

Table 5 3: Distribution Agreement in Point of Care Testing Market, 2008 – 2012

Table 5 4: Licensing Deals in Point of Care Testing Market, 2008,2009,2011,2012

Table 7 1: Cost Comparisons between POCT & Central Laboratory Testing (US$), 2009

Table 7 2: Hypothetical Labor Steps Involved in Central Laboratory Testing V/S POCT

Table 7 3: Barriers to Adoption & Scale-up of POC Technologies

Table 7 4: Technical, Administrative & Operational Barriers of POC Tests in Low & Middle Income Countries

Table 7 5: Health System Related Barriers of POC Tests in Low & Middle Income Countries

Table 7 6: Economic Barriers of POC Tests in Low & Middle Income Countries

To order this report: In_Vitro_Diagnostic Industry: Point of Care Testing Market and Forecast to 2016: Global Analysis

Nicolas Bombourg



US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
5 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.31 +1.44 0.07%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs